COLUMBUS, Ohio--(BUSINESS WIRE)--DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, announced today that Dr. John C. Byrd, M.D., has joined its scientific ...

DNA Nanobots – a leader in the design and delivery of DNA nanoparticles engineered for targeted therapeutics – announced that it has closed its pre-seed funding round. The funding round enables DNA ...

Platform company uses antibody-targeted DNA nanoparticles to deliver a wide range of therapeutic payloads to desired tissue. COLUMBUS, Ohio--(BUSINESS WIRE)-- DNA Nanobots, a leader in the design and ...

COLUMBUS, Ohio, December 17, 2025--(BUSINESS WIRE)--DNA Nanobots, a pioneer in self-assembling nanoscale therapeutics, today announced it has secured $3.5 million in funding from a prominent, family ...

DNA Nanobots has secured a $3.5 million investment from a prominent family office as it advances a non-viral gene delivery platform built around self-assembling nanoscale therapeutics. The Columbus, ...

Israeli researchers have created nanobot DNA structures inside a living cockroach, then watched their structure target one of the insect's cells. In "Universal Computing by DNA Origami Robots in a ...

Platform company uses antibody-targeted DNA nanoparticles to deliver a wide range of therapeutic payloads to desired tissue. “Most therapeutics fail in clinical trials,” said CEO and co-founder Jeff ...